| Serial Number | 98244532 |
| Word Mark | OJEMDA |
| Filing Date | Friday, October 27, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 22, 2025 |
| Registration Number | 7871548 |
| Registration Date | Tuesday, July 22, 2025 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 9, 2024 |
| Description of Mark | The mark consists of a stylized circle formed by a series of quadrilaterals with curved sides, centered around a stylized octagon with curved sides appearing to the left of the word OJEMDA. |
| Goods and Services | Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders; |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical information services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding oncological diseases and disorders |
| Goods and Services | Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, May 6, 2024 |
| First Use In Commerce Date | Monday, May 6, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, April 23, 2024 |
| First Use In Commerce Date | Tuesday, April 23, 2024 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 7, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, April 23, 2024 |
| First Use In Commerce Date | Tuesday, April 23, 2024 |
| Party Name | Day One Biopharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Party Name | Day One Biopharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Party Name | Day One Biopharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Event Date | Event Description |
| Tuesday, October 31, 2023 | NEW APPLICATION ENTERED |
| Tuesday, November 7, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 8, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, February 27, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, March 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 22, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 22, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 22, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 22, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, May 31, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 19, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 9, 2024 | PUBLISHED FOR OPPOSITION |
| Friday, January 10, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, January 10, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, January 10, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 27, 2025 | USE AMENDMENT FILED |
| Friday, February 28, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, May 21, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, May 22, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 3, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, June 27, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, July 16, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, July 22, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 22, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |